Saturday, Jun 10, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Health | Indiscriminate Use Of Plasma Therapy Not Good Icmr

Indiscriminate use of plasma therapy not good: ICMR

CPT did not lead to reduction in progression to severe Covid-19 or all-cause mortality in the group that received CPT as compared to the group that did not receive the therapy, said ICMR study

By PTI
Published Date - 04:55 PM, Wed - 18 November 20
Indiscriminate use of plasma therapy not good: ICMR
whatsapp facebook twitter telegram

New Delhi: The country’s apex health research body, ICMR, has issued an advisory stating that indiscriminate use of convalescent plasma therapy (CPT) in coronavirus infected patients is not advisable.

The Covid-19 caseload in India has mounted to over 89 lakh. In an “Evidence Based Advisory to address Inappropriate Use of Convalescent Plasma in Covid-19 Patients”, the Indian Council of Medical Research (ICMR) said that a potential donor for convalescent plasma should have sufficient concentration of antibody working against Covid-19.

Benefits of CPT in improving clinical outcomes, reducing severity of disease, duration of hospitalisation and mortality in Covid-19 patients are dependent on the concentration of specific antibodies in convalescent plasma that could neutralise the effects of SARS-CoV-2. CPT or passive immunotherapy has been tried in the past for treatment of viral infections like H1N1,

Ebola and SARS-CoV-1 etc. The ICMR recently conducted an open label phase II multicentre randomised controlled trial in India across 39 public and private hospitals on use of convalescent plasma in the management of cases with moderate COVID-19 disease (PLACID Trial).

It was concluded that CPT did not lead to reduction in progression to severe Covid-19 or all-cause mortality in the group that received CPT as compared to the group that did not receive the therapy.

“PLACID is the world’s largest pragmatic trial on CPT conducted in 464 moderately ill laboratory confirmed Covid-19 affected adults in real world setting wherein no benefit of use of CPT could be established,” the ICMR said.

Similar studies conducted in China and the Netherlands have also documented no significant benefit of CPT in improving the clinical outcomes of hospitalised Covid-19 patients, the advisory stated.

“Indiscriminate use of CPT is not advisable. It is speculated that convalescent plasma having low concentration of specific antibody against SARS-CoV-2 may be less beneficial for treating Covid-19 patients as compared to plasma with high concentration of such antibodies.

“This advisory, therefore, embraces the principle that a potential donor for convalescent plasma should have sufficient concentration of antibody working against Covid-19,” the advisory stated.

CPT should only be used, as advised by the ICMR for management of Covid-19 when specific criteria as mentioned are met, it stated. According to the advisory a potential donor of CPT can be a male or female, who has never been pregnant, in the age group of 18-65 years who after 14 days of symptom resolution (testing negative for Covid-19 is not necessary) can donate plasma.

  • Follow Us :
  • Tags
  • convalescent plasma
  • Convalescent Plasma therapy
  • Coronavirus
  • coronavirus infected

Related News

  • Lancet study: Over 11% of Indians suffer from diabetes

    Lancet study: Over 11% of Indians suffer from diabetes

  • Here’s why some Covid patients continue to have difficulty in exercising

    Here’s why some Covid patients continue to have difficulty in exercising

  • Gird up for next pandemic which could be ‘even deadlier’: WHO warns countries

    Gird up for next pandemic which could be ‘even deadlier’: WHO warns countries

  • Health and Tech: Integrative-medicine healthcare model is future

    Health and Tech: Integrative-medicine healthcare model is future

  • India records 9,355 fresh Covid-19 infections, 26 deaths

    India records 9,355 fresh Covid-19 infections, 26 deaths

  • India records 12,193 fresh COVID-19 cases, 42 more fatalities

    India records 12,193 fresh COVID-19 cases, 42 more fatalities

Latest News

  • Kothagudem: Dr GSR Trust launches mobile clinic for remote agency villages

    4 mins ago
  • Telangana policing system a role model for India: HM Mahmood Ali

    8 mins ago
  • Celebrate Father’s Day with the perfect gift for a ‘green dad’

    14 mins ago
  • Mercury levels drop, rains and gusty winds in store for Hyderabad in next four days

    18 mins ago
  • French Open: Korneeva clinches junior title with win over Alarcon

    23 mins ago
  • Congress padayatras a domination tactic: Gutha

    28 mins ago
  • BJP alternative to BRS, says Mahendra Nath Pandey

    34 mins ago
  • FSTPs ready for inauguration in Jogulamba Gadwal district

    39 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam